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UNIT A3.3Intra-Axial Primary Brain Tumors
MRI provides the greatest sensitivity for the detection of brain tumors and information
regarding detailed anatomical location and extent, and often elucidates important under-
lying histopathologic features (Atlas and Lavi, 1996). The majority of primary brain
tumors in adults are found in the supratentorial compartment, while tumors in pediatric
patients are infratentorial in location. This unit presents the set of sequences used for
imaging all types of primary intra-axial brain tumors, whether infiltrative (i.e., astrocy-
toma, oligodendroglioma, lymphoma) or circumscribed (i.e., ganglioglioma, cystic astro-
cytoma), and specific modifications will be discussed where necessary. The sequences
described in this unit are based on the authors’ experience with a 1.5 T scanner (Echospeed
GE Medical Systems), but can be expected to be equally applicable to other field strengths
and scanners from other manufacturers.
BASIC
PROTOCOL 1
RULE OUT (R/O) PRIMARY CEREBRAL TUMOR
Spin-echo and fast spin-echo imaging essentially provide all of the information needed
to make an accurate diagnosis when evaluating for primary brain tumors. Contrast-en-
hanced imaging is a critical part of the MR evaluation of brain tumors. The non-contrast
spin-echo and fast-spin echo images (sequences 2 and 3) provide information regarding
tissue characteristics and extent of tumor. Fluid attenuated inversion recovery (FLAIR)
images (sequence 4) and the post-contrast T1-weighted images (sequence 5) are most
sensitive for evaluating spread of tumor to the adjacent meninges (Singer, 1998). Enhance-
ment of a brain lesion indicates breakdown of the blood-brain barrier and non-enhancing
portions of a lesion may indicate intra-tumoral cysts or necrosis. Sequences 1 to 5
comprise the preferred protocol.
Gradient echo images depict regions of hypointensity within a tumor that may represent
either calcification, blood products or intra-tumoral vessels (Atlas et al., 1988). Gradient
echo images (sequence 6) are added on to the Basic Protocol described in this unit when
tumors that calcify (i.e., oligodendroglioma, ganglioglioma) or hemorrhage (high grade
gliomas, ependymomas) are suspected.
Table A3.3.1 lists the hardware necessary to perform the procedure, along with appropri-
ate parameters.
NOTE: Be sure that technologists and nurses have immediate access to any equipment
such as crash carts or oxygen that may be necessary in the event of an emergency. Contrast
reactions are rare, but the resources are necessary.
Materials
Intravenous contrast agent (e.g., Magnevist, Omniscan, or Prohance)
Normal saline (0.9% NaCl), sterile
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Table A3.3.1 Equipment Parameters for Imaging Brain Tumors
Coil Type Quadrature head coil
Gradient coil strength 25 mT/m (or whatever the system permits)
Cardiac gating No
Peripheral gating For safety only
Respiratory gating No
Respirator If required by patient
Oxygen If required by patient
Motion cushions No
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Set up patient and equipment
1. Interview (screen) the patient to ensure that he or she has no contraindications to the
MRI examination, such as a cardiac pacemaker or other implants containing ferro-
magnetic materials. Question the patient regarding any health conditions that may
require the presence of specific emergency equipment during the scanning procedure,
or necessitate any other precautions.
Generally standard screening forms are used for all patients scanned in a magnetic
resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
(1996) for discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
form.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience in the magnet, and how to behave, including the following:
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be able
to communicate with you at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results the patient should not talk, and should avoid or minimize
swallowing or other movement, during each scan—i.e., as long as the banging
sounds continue. Between scans, talking and swallowing are allowed in most
cases, but should be avoided when comparative positional studies are being
performed; the patient will be informed when this is the case.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
6. Have the patient lie in the supine position on the table. Set up all monitoring
equipment before or right after the patient lies down.
7. Center the patient in the head coil at the region where the key information is desired.
Make sure the head and neck are constrained to prevent motion.
Generally the patient’s head is fixed so that the head is horizontal (not tilted) and the neck
and head lie along the axis of the patient table.
8. If needed, place a pillow or other support under the knees to make the patient more
comfortable.
9. Use the centering light to position the patient (centered on the nasion) and put him
or her into the center of the magnet.
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Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
10. If the patient is unable to hold still, provide an appropriate sedative.
Sequence 1: Localizer
11. Run sequence 1 according to Table A3.3.2. The sagittal scout view is used to prescribe
the transverse and coronal planes.
Sequence 2: T1-weighted scan
12. Run sequence 2 according to Table A3.3.3.
Sequence 3: T2-weighted scan
13. Run sequence 3 according to Table A3.3.4.
Sequence 4: Fast fluid attenuated inversion recovery (FLAIR)
14. Run sequence 4 according to Table A3.3.5.
Sequence 5: Post-contrast imaging
15. Remove the patient from the scanner. The patient should not move on the table.
Establish an intravenous line from which the contrast agent can be injected, and attach
this line securely to the patient so that movement into or out of the magnet will not
pull at the patient’s arm. Move the patient back into the scanner.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet,
with no intervening motion, between the scans run before contrast agent injection and those
run after injection.
16. Leaving the patient in the magnet, inject the contrast agent, flush the line with 10 ml
saline.
A dose of 0.1 mmol/kg of contrast agent is usually given.
A delay in scanning may actually be beneficial when evaluating for metastases, which is
one of the reasons we scan in multiple planes after intravenous contrast administration.
Table A3.3.2 Primary Clinical Imaging Parameters for Sequence 1: Localizer
(T1-Weighted)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Laser light centered on nasion
Echo time (TE) 11 msec (or select “minimum
full” echo time)
Receiver bandwidth (RBW) 10 kHz
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected, (Nx, Ny) 256, 192
Slice thickness (∆z) 5 mm
Number of slices 20 or as many as needed to cover
the region of interest
Slice gap 2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Saturation pulses Not applicable
Scan time ∼1 min, 36 sec
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Table A3.3.3 Primary Clinical Imaging Parameters for Sequence 2
(T1-Weighted)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 11 msec (or select “minimum
full” echo time)
Receiver bandwidth (RBW) 10 kHz
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected, (Nx, Ny) 256, 192
Slice thickness (∆z) 5 mm
Number of slices 20 or as many as needed to cover
the region of interest
Slice gap 2.5 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding Yes
Saturation pulses Not applicable
Scan time 1 min, 36 sec
Table A3.3.4 Primary Clinical Imaging Parameters for Sequence 3
(T2-Weighted)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 102 msec (effective)
Receiver bandwidth (RBW) 16 kHz
Echo train length (ETL) 8
Repeat time (TR) 3600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected, (Nx, Ny) 256, 192
Slice thickness (∆z) 5 mm
Number of slices 20 or as many as needed to cover
the region of interest
Slice gap 2.5 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding Yes
Saturation pulses Not applicable
Scan time ∼1 min, 30 sec
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17. Acquire the post-contrast images using the same parameters as in sequence 2
(T1-weighted).
In addition to the transverse plane, the coronal plane is routinely obtained, with the
following changes to the parameters in sequence 2: (a) flow compensation is on; (b) TE is
15 msec (prolonged due to flow compensation gradients); and (c) it is not necessary to
Table A3.3.5 Primary Clinical Imaging Parameters for Sequence 4 (Fast
FLAIR)
Patient position Supine
Scan type Inversion recovery fast spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 120 msec (effective)
Receiver bandwidth (RBW) 16 kHz
Echo train length (ETL) 8
Repeat time (TR) 10,000 msec
Inversion time (TI) 2200 msec
Flip angle (FA) 180°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected, (Nx, Ny) 256, 192
Slice thickness (∆z) 5 mm
Number of slices 20 or as many as needed to cover
the region of interest
Slice gap 2.5 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding Yes
Saturation pulses Not applicable
Scan time ∼5 min
Table A3.3.6 Primary Clinical Imaging Parameters for Sequence 6
Patient position Supine
Scan type 2-D gradient recalled echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 30 msec
Receiver bandwidth (RBW) 4 kHz
Repeat time (TR) 500 msec
Flip angle (FA) 15°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected, (Nx, Ny) 256, 192
Slice thickness (∆z) 5 mm
Number of slices 20 or as many as needed to cover
the region of interest
Slice gap 2.5 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding Yes
Saturation pulses Not applicable
Scan time ∼2 min
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swap read and phase encoding directions. In patients requiring sedation and in all pediatric
patients, we also routinely obtain a third post-contrast plane of imaging (sagittal).
Sequence 6: Gradient echo imaging to examine calcified or hemorrhagic tumor
18. Run sequence 6 according to Table A3.3.6.
Gradient echo images depict regions of hypointensity within tumors that may represent
either calcification, blood products, or flow voids from intra-tumoral vessels. This sequence
is useful to obtain in lesions that frequently calcify (i.e., oligodendroglioma, ganglio-
glioma) or hemorrhage (i.e., high grade gliomas and ependymomas).
ALTERNATE
PROTOCOL
OPTIONAL SEQUENCES
The set of imaging sequences described in Basic Protocol 1 often provide virtually all the
information necessary for the diagnosis of primary intra-axial brain tumors. Studies are
being conducted to investigate the potential value of diffusion-weighted imaging (DWI;
Stejskal and Tanner, 1965; Tien et al., 1994) and perfusion-weighted imaging (Alsop and
Detre, 1998; using either contrast bolus techniques or continuous arterial spin labeling)
in routine tumor imaging. Preliminary studies suggest that DWI may have potential for
detecting intra-tumoral necrosis.
The main indication for obtaining proton MR spectroscopy (MRS) data is to help
distinguish a neoplastic from a non-neoplastic lesion (see Figure A3.3.1); however, proton
MR spectroscopy (sequence 7), does provide biochemical information regarding brain
tumors that may be useful to further categorize a specific lesion (i.e., high or low grade
tumor) (Meyer et al., 1999). Whole brain chemical-shift imaging (CSI) maps may also
be potentially useful in the investigation of brain tumors by providing visual metabolite
maps, rather than spectral data.
Set up patient and equipment
1. Follow the setup for Basic Protocol 1 and obtain the necessary pre- and post-contrast
images (steps 1 to 17). The lesion is localized on a transverse image (typically the
post-contrast transverse T1-weighted image).
Voxel placement requires physician input to ensure the correct region of interest is being
studied. Two separate scans are performed: one with the voxel placed over the area in
question (typically the enhancing portion of the lesion), the other scan is performed with
the voxel placed in the contralateral hemisphere (in a “normal appearing” analogous area
of the brain). The screen should always be saved to document placement of the voxel.
Sequence 7: Proton (1H) MR spectroscopy
The Proton Brain Exam-Single Voxel (PROBE-SV) on GE systems is a fully automated
software package that is widely available and is performed using the single voxel
technique (8 cm3). A high field system is required to obtain good spectra. There are 2
possible localization methods: STEAM (stimulated echo acquisition mode) or PRESS
(point-resolved spectroscopy). The sequence parameters can be set by the user (TR, TE,
voxel size). Short TE spectroscopy has the advantage of providing more information, since
more peaks are visible for analysis while maximizing the detection of lipid-breakdown
products. Long-TE spectra have less baseline distortion and are easier to quantify. Since
there is a √2 decrease in the signal-to-noise ratio with STEAM sequences, the PRESS
sequence is usually preferred. Spectra obtained following the administration of intrave-
nous contrast may be altered (Sijens et al., 1997). In particular, studies have shown a mean
loss of 15% of the peak area of choline-containing compounds without significant changes
in creatine (Cre) or N-acetyl aspartate (NAA) (Sijens et al., 1997). In routine clinical
practice, the spectra are obtained following the administration of intravenous contrast and
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the voxel is positioned over the solid (enhancing) portion of the lesion so that theoretically
signal is acquired from viable tumor tissue.
2. Perform automated shimming and water suppression, center the voxel over the
enhancing portion of the lesion, and run sequence 7 according to Table A3.3.7.
3. After completion of the scan, a spectrum will appear on the screen and the values for
the spectrum should be saved.
4. Place the voxel in the contralateral hemisphere and repeat the scan.
A
B C
NAA
CreCho
MyoI
3.0 2.0 1.03.0 2.0 1.0
Cho
Lac
Figure A3.3.1 (A) T2-weighted fast spin echo image (TR = 2000 msec, TE = 105 msec, Nacq = 2)
through a large mass in the right thalamus and basal ganglia of a 35 year old female with headaches.
Water suppressed protocon spectroscopy was performed using PRESS sequence (point resolved
spectroscopy) in an 8-cm3 voxel with a TE = 144 msec positioned (B) over the tumor mass and (C)
on the contralateral side at the equivalent location. Resonances are labeled as: Lac = lactate; NAA
= N-acetyl aspartate; Cre = creatine; Cho = choline; MyoI = myoinositol. The horizontal axis is given
in parts per million (ppm). Automated software used creatine as reference signal intensity quantified
the NAA as significantly decreased in the tumor and NAA/Cre ratio of 1.47 in the normal tissue. The
presence of lactate, markedly reduced NAA and elevated choline, is characteristic of neoplasm.
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5. After completion of the scan, another spectrum will appear on the screen and the
values for the spectrum should be saved.
Sequence 8: 3-D short TR gradient echo
6. In cases where it is difficult to differentiate an intra-axial peripheral exophytic
tumor from an extra-axial lesion impinging on the brain, obtain a thin slice 3-D
gradient echo sequence to better evaluate the brain-tumor interface outlined in
Table A3.3.8.
Table A3.3.7 Primary Clinical Imaging Parameters for Sequence 7 (1H-MR
Spectroscopy)
Patient position Supine
Scan type PROBE-SV
Voxel center See text (steps 2 and 4)
Echo time (TE) 35 msec and 144 msec
Repeat time (TR) 2000 msec
Flip angle (FA) 90°
Voxel size (∆x, ∆y, ∆z) 2 cm, 2 cm, 2 cm
Number of acquisitions (Nacq) 8a and 128b
Saturation pulses Water
Scan time ∼5 min
aWithout water suppression.
bWith water suppression.
Table A3.3.8 Primary Clinical Imaging Parameters for Sequence 8 (3-D Short
TR Gradient Echo)
Patient position Supine
Scan type 3-D gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 5 msec (or select the minimum
value when possible)
Repeat time (TR) 35 msec
Flip angle (FA) 45°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 1.5 mm
Number of slices ∼40
Slice gap 0
Number of acquisitions (Nacq) 1
Swap read and phase encoding Yes
Saturation pulses Not applicable
Scan time ∼5 min
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BASIC
PROTOCOL 2
R/O PRIMARY CEREBELLAR AND BRAINSTEM TUMOR
In pediatric patients, tumors are most commonly found in the infra-tentorial compartment
(posterior fossa). In adults, the majority of lesions found in the posterior fossa are
metastases; however, primary tumors do occur and the most common primary cerebellar
tumor in adults is hemangioblastoma. The sequences described in Basic Protocol 1 should
be obtained to evaluate posterior fossa tumors.
Set up patient and equipment
1. Follow the setup for Basic Protocol 1 (steps 1 to 10).
2. Run sequences 1 to 5.
COMMENTARY
Background Information
The incidence of brain tumors varies accord-
ing to age and recent literature suggests inci-
dence trends have stabilized for all age groups
except in individuals greater than 85 years
where it is increasing (15.7 cases of cancer per
100,000 individuals). Improvements in diagno-
sis may explain the observed patterns in brain
cancer trends (Legler et al., 1991). While com-
puted tomography (CT) is often more readily
available, and therefore the first examination
performed for suspected intracranial pathol-
ogy, magnetic resonance imaging (MRI) has
proven to be invaluable in refining the diagno-
sis. MRI provides greater sensitivity for the
detection of brain tumors and detailed anatomi-
cal information (Atlas and Lavi, 1996). Con-
trast enhanced imaging in more than one plane
is essential to evaluate intra-axial brain tumors.
Critical Parameters and
Troubleshooting
In pediatric patients and other subjects re-
quiring sedation, the authors feel that 3 planes
(transverse, coronal, sagittal) of imaging
should be obtained in the post-contrast acqui-
sition when evaluating brain tumor patients.
Proton MR spectroscopy studies have shown
that contrast administration will alter spectra
by decreasing the peak area of choline- contain-
ing compounds. Since tumors are frequently
heterogeneous histologically, placement of the
voxel in different regions of the tumor may
yield different MR spectroscopy results. The
relatively large voxel size also results in volume
averaging with the adjacent brain. In routine
clinical use, the post-contrast images are used
to identify the solid appearing portion of the
lesion and the voxel is placed in the solid
(enhancing portion) of the lesion.
Anticipated Results
The goal in evaluating cerebral neoplasms
is to image the entire lesion, localize it to the
appropriate compartment of the brain, and at-
tempt to predict the underlying histology. Con-
ventional MR sequences offer superb anatomi-
cal detail and tissue characterization of brain
tumors. Contrast-enhanced imaging is critical
to evaluate all brain tumors and helps to assess
the integrity of the blood-brain barrier and
depict intra-tumoral cystic or necrotic regions.
Conventional MR techniques cannot reliably
distinguish high-grade from low-grade tumors.
Proton MR spectroscopy offers metabolic in-
formation and helps predict the relative aggres-
siveness of a lesion by evaluating metabolite
ratios (NAA/Cre) and identifying metabolites
such as lactate (indicator of anaerobic gly-
colysis; Meyer et al., 1999).
Time Considerations
The Basic Protocol 1 detailed in this unit
should take ∼30 min to complete. Proton MR
Spectroscopy may add ∼10 to 15 min to the
imaging session.
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